文献速递瓣膜外科主动脉外科心外重症与机械循环支持

当代TAVR重大并发症与救治失败的发生率、预测因素及结局

Incidence, Predictors, and Outcomes of Major Transcatheter Aortic Valve Replacement (TAVR) Complications and Failure-to-Rescue in the Contemporary Era.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2026-01-01

重大并发症患者院内死亡率为26.0%,显著高于无并发症者的1.0%(P<.001),卒中发生率亦更高(7.5% vs 1.8%,P<.001)。年龄<65岁、二叶式主动脉瓣、胸主动脉瘤和女性是并发症的独立预测因素,择期入院为保护因素。

要点

  • TAVR重大并发症发生率为1.2%,但院内死亡率高达26.0%。
  • 年龄<65岁、二叶式主动脉瓣、胸主动脉瘤和女性增加并发症风险。
  • 并发症患者中VA-ECMO置管是死亡的最强预测因素(OR 10.36)。

核心结论

  • TAVR需外科干预的重大并发症虽占比稳定,但绝对数量随TAVR总量增长而增加,且与超过25%的院内死亡率相关。

研究设计与样本

  • 重大并发症定义为需行外科主动脉瓣置换、冠状动脉旁路移植、主动脉干预、心包引流、VA-ECMO、心脏修复或诊断为主动脉夹层/破裂。

主要发现

  • 重大并发症患者院内死亡率为26.0%,无并发症者为1.0%(P<.001)。
  • 重大并发症患者卒中发生率为7.5%,无并发症者为1.8%(P<.001)。
  • 重大并发症患者住院时间更长(8天 vs 2天),住院费用更高(79302美元 vs 45469美元)。
  • 并发症的独立预测因素包括年龄<65岁(OR 2.27)、二叶式主动脉瓣(OR 1.79)、胸主动脉瘤(OR 1.49)和女性(OR 1.24),择期入院为保护因素(OR 0.51)。

关键数值与推荐

  • 并发症患者中死亡的最强预测因素为VA-ECMO置管(OR 10.36)、心脏腔室修复(OR 3.14)和主动脉夹层/破裂(OR 1.68)。

临床怎么用

  • 对年龄<65岁、二叶式主动脉瓣、胸主动脉瘤或女性TAVR患者应加强围术期风险评估与外科后备支持。
  • TAVR术后发生重大并发症需外科干预时,应警惕极高的死亡风险,尤其是需VA-ECMO支持者。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: As transcatheter aortic valve replacement (TAVR) expands to lower-risk populations, understanding contemporary patterns of complications requiring surgical intervention remains critical. This study examines the incidence, predictors, and outcomes of major TAVR complications. METHODS: The National Inpatient Sample (2016-2021) was queried to identify adult patients undergoing TAVR. Major complications were defined as surgical aortic valve replacement, coronary artery bypass grafting, aortic intervention, pericardial drainage, VA-ECMO, cardiac repair, or diagnosis of aortic dissection/rupture. Multivariable logistic regression identified predictors of complications and failure-to-rescue. RESULTS: Among 383 395 TAVRs, 4685 (1.2%) experienced major complications. Overall in-hospital mortality was 1.3%. Mortality was 26.0% in patients with major complications versus 1.0% without (P < .001). Stroke rates were also higher in patients with major complications (7.5% versus 1.8%, P < .001). Complications were associated with longer length of stay (8 vs 2 days) and higher hospital costs ($79,302 vs $45,469). Independent predictors of complications included age <65 (OR 2.27), bicuspid aortic valve (OR 1.79), thoracic aortic aneurysm (OR 1.49) and female sex (OR 1.24), while elective admission was protective (OR 0.51). Among patients with complications, VA-ECMO cannulation (OR 10.36), cardiac chamber repair (OR 3.14), and aortic dissection/rupture (OR 1.68) were strongest predictors of mortality. CONCLUSIONS: While the proportion of TAVR patients experiencing surgical emergencies has remained stable over time, the overall prevalence is increasing with the growth of TAVR, and these complications are associated with an in-hospital mortality rate of greater than 25%. Younger age, female sex, bicuspid valve, and thoracic aneurysm are associated with increased risk of major complications.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Catalano MA, Bazianos D, Nathan A, et al. Incidence, Predictors, and Outcomes of Major Transcatheter Aortic Valve Replacement (TAVR) Complications and Failure-to-Rescue in the Contemporary Era. Interdiscip Cardiovasc Thorac Surg. 2026. PMID: 41416902. doi:10.1093/icvts/ivaf311

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。